Effect of natalizumab on circulating CD4+ T-cells in multiple sclerosis.

por Lars Börnsen, Jeppe Romme Christensen, Rikke Ratzer, Annette Bang Oturai, Per Soelberg Sørensen, Helle Bach Søndergaard, Finn Sellebjerg
Publicado 2012

Endogenous and recombinant type I interferons and disease activity in multiple sclerosis.

por Finn Sellebjerg, Martin Krakauer, Signe Limborg, Dan Hesse, Henrik Lund, Annika Langkilde, Helle Bach Søndergaard, Per Soelberg Sørensen
Publicado 2012